Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Berberine | Pentadecanoic Acid (C15:0 / Fatty15) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 500mg 2-3x daily (1000-1500mg total) | — |
| Timing | With meals or immediately before meals (reduces postprandial glucose spike). Must be taken with food. | — |
| Cycle Duration | Cycle 8-12 weeks on, 4 weeks off (or continuous under practitioner supervision) | — |
| Evidence Level | strong_human | Emerging |
Berberine activates AMP-activated protein kinase (AMPK), the master metabolic sensor, mimicking many effects of caloric restriction and exercise. It inhibits mitochondrial Complex I, increasing the AMP:ATP ratio which triggers AMPK. Downstream effects include enhanced GLUT4 translocation (glucose uptake), inhibition of HMG-CoA reductase (cholesterol synthesis), upregulation of LDL receptor expression, and suppression of PCSK9. It also modulates gut microbiome composition, increasing short-chain fatty acid-producing bacteria.
500mg 2-3x daily (1000-1500mg total)
With meals or immediately before meals (reduces postprandial glucose spike). Must be taken with food.
Cycle 8-12 weeks on, 4 weeks off (or continuous under practitioner supervision)
Odd-chain saturated fatty acid identified as essential. Strengthens cell membranes by integrating into phospholipid bilayer, activates AMPK and PPAR-alpha/delta, and inhibits mTOR. Repairs mitochondrial function. Epidemiologically associated with reduced cardiometabolic disease.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →